ATE76099T1 - Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen. - Google Patents

Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen.

Info

Publication number
ATE76099T1
ATE76099T1 AT87402104T AT87402104T ATE76099T1 AT E76099 T1 ATE76099 T1 AT E76099T1 AT 87402104 T AT87402104 T AT 87402104T AT 87402104 T AT87402104 T AT 87402104T AT E76099 T1 ATE76099 T1 AT E76099T1
Authority
AT
Austria
Prior art keywords
recombinant
cho cells
vectors
dna sequence
programming
Prior art date
Application number
AT87402104T
Other languages
English (en)
Inventor
Robert Drillien
Daniele Spehner
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE76099T1 publication Critical patent/ATE76099T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87402104T 1986-09-23 1987-09-21 Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen. ATE76099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8613272A FR2604183B1 (fr) 1986-09-23 1986-09-23 Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
EP87402104A EP0262043B1 (de) 1986-09-23 1987-09-21 DNS-Sequenz, Vektoren, rekombinante Viren und Verfahren zur Verwendung rekombinanter Vaccinia-Viren, die sich in CHO-Zellen vermehren können

Publications (1)

Publication Number Publication Date
ATE76099T1 true ATE76099T1 (de) 1992-05-15

Family

ID=9339184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87402104T ATE76099T1 (de) 1986-09-23 1987-09-21 Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen.

Country Status (9)

Country Link
US (1) US5830688A (de)
EP (1) EP0262043B1 (de)
JP (2) JP2683804B2 (de)
AT (1) ATE76099T1 (de)
AU (1) AU598859B2 (de)
CA (1) CA1341242C (de)
DE (1) DE3779032D1 (de)
DK (1) DK498387A (de)
FR (1) FR2604183B1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5364773A (en) * 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
AU3776689A (en) * 1988-06-10 1990-01-05 Applied Biotechnology, Inc. Method of selecting for recombinant pox viruses
US5225336A (en) * 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
DE4090351T1 (de) * 1989-03-08 1997-07-24 Health Research Inc Rekombinantes Pockenvirus-Wirtsselektionssystem
US6514502B1 (en) 1999-01-26 2003-02-04 Schering-Plough Veterinary Corporation Propagation of bovine cononavirus in chinese hamster ovary cells
US10544397B2 (en) * 2013-11-01 2020-01-28 Sementis Limited Viral vector manufacture
US20260078353A1 (en) 2022-06-30 2026-03-19 Bavarian Nordic A/S Mammalian Cell Line for the Production of Modified Vaccinia Virus Ankara (MVA)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769330A (en) * 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
AU570940B2 (en) * 1982-11-30 1988-03-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for producing poxvirus recombinants for expression offoreign genes
DE3576360D1 (de) * 1984-05-22 1990-04-12 Transgene Sa Expressionsvektoren fuer faktor ix und aktionsfaktor ix produzierende zellinien.

Also Published As

Publication number Publication date
FR2604183A1 (fr) 1988-03-25
DK498387D0 (da) 1987-09-22
FR2604183B1 (fr) 1988-12-30
JPH09206084A (ja) 1997-08-12
US5830688A (en) 1998-11-03
DE3779032D1 (de) 1992-06-17
EP0262043B1 (de) 1992-05-13
EP0262043A1 (de) 1988-03-30
DK498387A (da) 1988-03-24
JPS63157988A (ja) 1988-06-30
JP2818836B2 (ja) 1998-10-30
AU598859B2 (en) 1990-07-05
AU7890687A (en) 1988-05-19
CA1341242C (fr) 2001-06-05
JP2683804B2 (ja) 1997-12-03

Similar Documents

Publication Publication Date Title
DE3382837D1 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
DK179290A (da) Rekombinante cmv-neutraliserende proteiner
ATE169673T1 (de) Rekombiniertes alzheimer amyloid-protein
AU580059B2 (en) Vaccine against rabies and preparation process thereof
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
DE3779032D1 (de) Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia-viren, die sich in cho-zellen vermehren koennen.
IL62833A (en) Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
ATE103980T1 (de) Das f-protein vom aids-virus enthaltender impfstoff.
DK0414035T3 (da) Gibbonabe-leukæmi-virusreceptor
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
ZA813110B (en) Dna sequences, recombinant dna molecules and processes for producing polypedtides with the specificity of foot and mouth disease viral antigens
ATE62019T1 (de) Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee